Dakota
Rea
Founder & Lead Inventor, FOY Limited
Dakota Rea is a multifaceted scholar, entrepreneur, and visionary whose career spans law, academia, biotechnology, and philanthropy. With degrees from Harvard and Oxford, certifications from MIT and Wharton, and experience across 60+ countries, Dakota brings a truly global perspective to every endeavor.
As the founder and lead inventor of FOY Limited, Dakota conceived and developed the world's first patent-pending system for safely delivering Turritopsis dohrnii immortal jellyfish polypeptides into human and animal subjects — a breakthrough that stands to redefine the boundaries of longevity medicine.
A Journey of Purpose
Dakota Rea's journey began with an insatiable curiosity about how technology and ethics intersect in shaping human society. This curiosity led to an academic path through some of the world's most prestigious institutions — Harvard Business School, the University of Oxford, MIT, and the Wharton School — where he developed the intellectual foundation for a career defined by bridging disciplines that others treat as separate.
At Oxford, Dakota's research focuses on the philosophy of Jeremy Bentham, particularly as it applies to modern ethical dilemmas in artificial intelligence and emerging biotechnology. As a Jeremy Bentham Scholar, he explores how utilitarian principles can guide the development of systems — whether computational or biological — that maximize benefit while minimizing harm. This philosophical rigor informs every aspect of FOY Limited's approach to responsible scientific innovation.
Beyond academia, Dakota has built a reputation as a leading voice on generational market dynamics and enterprise strategy. His insights have been sought by Fortune 500 companies and startups across 60+ countries, and he has been responsible for over $2 billion in AI and innovation value creation. This commercial acumen is what positions FOY Limited not merely as a scientific endeavor, but as a commercially viable, market-ready enterprise.
Currently serving as a UK Solicitor Trainee at Slaughter and May — one of the world's most prestigious law firms — and tutored by a member of the Oxford Faculty of Law, Dakota brings unparalleled legal expertise to the protection and commercialization of FOY Limited's intellectual property. He understands not only how to invent, but how to defend, license, and scale a patent portfolio in a global regulatory environment.
As founder of the Tudor Foundation, Dakota has demonstrated a lifelong commitment to preserving humanity's legacy for future generations. FOY Limited is the natural extension of this mission — not to monuments of stone, but to the biological potential of the human species itself. The invention of a safe delivery mechanism for Turritopsis dohrnii polypeptides represents, in Dakota's view, the most consequential contribution any individual can make to the long-term flourishing of humanity.
What Dakota Brings to FOY
Biomedical Innovation
Pioneer in applying marine biology and polypeptide science to human longevity research, with a focus on safe, patent-protected delivery mechanisms for novel biological compounds.
AI Ethics & Responsible Innovation
Leading researcher on ethical frameworks for artificial intelligence and emerging biotechnology, ensuring that transformative science serves humanity's best interests with appropriate safeguards.
Corporate Law & IP Strategy
UK Solicitor Trainee at Slaughter and May with deep expertise in intellectual property protection, corporate transactions, and the legal architecture required to commercialize breakthrough patents.
Global Market Strategy
Recognized voice on generational market dynamics and enterprise strategy, with insights sought by Fortune 500 companies across 60+ countries and $2B+ in AI and innovation value created.
Scientific Entrepreneurship
Proven track record of founding and scaling purpose-driven ventures that bridge cutting-edge research and real-world commercial impact, from the Tudor Foundation to FOY Limited.
Longevity Science Advocacy
Passionate advocate for the reclassification of aging as a treatable disease and national security priority, aligning FOY Limited's mission with the emerging global consensus on longevity medicine.
Milestones & Achievements
Jeremy Bentham Scholar — University of Oxford
Selected as a Jeremy Bentham Scholar at Oxford, conducting advanced research on utilitarian philosophy, AI ethics, and the intersection of emerging biotechnology with legal and moral frameworks.
Founder & Lead Inventor — FOY Limited
Conceived and developed the world's first patent-pending delivery system for safely administering Turritopsis dohrnii immortal jellyfish polypeptides in human and animal subjects, founding FOY Limited to bring this breakthrough to market.
UK Solicitor Trainee — Slaughter and May
Joined one of the world's most prestigious law firms as a Solicitor Trainee, tutored by a member of the Oxford Faculty of Law, advising on complex corporate and commercial matters.
AI Ethics Research — Harvard University
Conducted groundbreaking research on responsible AI development and ethical frameworks at Harvard, establishing a foundation for technology-driven biomedical innovation guided by rigorous ethical principles.
MIT & Wharton Certifications
Completed advanced certifications at MIT and the Wharton School, deepening expertise in technology commercialization, venture strategy, and biotech market development.
Founded the Tudor Foundation
Established the Tudor Foundation to preserve England's Tudor architectural heritage and support academic research, demonstrating a lifelong commitment to protecting humanity's legacy for future generations.
Harvard Business School
Graduated from Harvard Business School with a focus on entrepreneurship and innovation, acquiring the strategic and commercial acumen to translate scientific breakthroughs into world-changing enterprises.
Ready to Partner with FOY Limited?
Serious pharmaceutical and research organizations are invited to initiate a partnership discussion. Full technical details are disclosed exclusively to NDA-approved parties.